{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3874, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "comparison_table", "function": "analyze_data", "notes": "Forest plot showing hazard ratios with 95% confidence intervals for multiple clinical subgroups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/29", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-29", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 30, "from": 26, "beatId": "617689da-c69b-43c7-8222-b2a08def2699", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the positive results of the NIAGARA trial.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "comparison_table", "function": "analyze_data", "notes": "The table compares safety data across various categories of adverse events, including grade 3/4, serious AEs, and treatment-related outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/30", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-30", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 30, "from": 26, "beatId": "617689da-c69b-43c7-8222-b2a08def2699", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the positive results of the NIAGARA trial.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "comparison_table", "function": "analyze_data", "notes": "The chart uses a diverging bar structure to compare two treatment arms side-by-side.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/31", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-31", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/32", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-32", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "cover", "function": "front_matter", "notes": "Includes corporate branding and a biological illustration of an antibody-drug conjugate or similar protein structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/33", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-33", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/34", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-34", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-row structure to categorize reasons for confidence: clinical evidence, safety/experience, and implementation/stakeholder alignment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/35", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-35", "loopMatches": [ { "to": 35, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4", "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.", "position": 0, "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "team_bio", "function": "introduce_nominees", "notes": "Slide lists 6 internal leaders and 1 external expert.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/36", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "cover", "function": "front_matter", "notes": "The slide features a 3D rendering of an antibody molecule.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/37", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart is a stacked area chart showing market growth by target segment (HER2, TROP2, Nectin4, etc.).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/38", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "kpi_overview", "function": "present_solution", "notes": "The slide uses a horizontal bar chart to represent clinical development stages for six different ADC assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/39", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide compares plasma concentration over time for two different ADCs, showing the stability of the ADC vs the mAb and the low levels of free payload.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/40", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "key_takeaways", "function": "summarize", "notes": "Waterfall plot shows best change in target lesion size; includes CA-125 response markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/41", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Waterfall plot shows RECIST v1.1 response criteria. Includes legend for dose levels and callout boxes for clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/42", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized 3D rendering of a bispecific antibody molecule.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/43", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "other", "function": "present_solution", "notes": "The slide highlights the structural design (knob-into-hole) and clinical development pipeline for two specific IO assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/44", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "key_takeaways", "function": "summarize", "notes": "WCLC conference presentation slide. Includes waterfall plot and summary table of ORR and treatment continuation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/45", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Spider plot (swimmer plot variant) showing individual patient response trajectories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/46", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "key_takeaways", "function": "summarize", "notes": "Waterfall plot shows tumor shrinkage; includes key clinical metrics (ORR, mPFS) and safety/future trial status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/47", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/48", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a bridge/waterfall structure to show revenue growth drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/49", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a grid-based layout to organize events by year, with checkmarks indicating completed or high-priority milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/50", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "team_bio", "function": "introduce_nominees", "notes": "The slide lists six key executives with their titles and headshots.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/51", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-51", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/52", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-52", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/53", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-53", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a matrix structure to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast, CAPItello) by patient population and treatment line.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/54", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-54", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2e43-774b-aad6-58a03a29d59d", "docSlug": "207557819f8810b573d3e2a3179a9bac", "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/55", "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d", "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-55", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/-zuNkRTvEnoTMmg7N8-5pgCOc5O7k05HyicoVlSSgbE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/1", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/0i1CF1g21WpK6SFmkTjkx3bLv5YiJ5pWrMpyGK6OU0s/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Tqov8nw0BV55Ft5lZ1ixXghU1PwtXDRUv4TBZn9Otfc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/aoA6joonwq92FLYuI5NdXkInTiwLz405k6Gptlb_H48/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wN2RhODY5MGRlZDVkMDc5ZDY3NjA4ODlkMmY1OThkOC9wMDAxLnBuZw" }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/2", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "timeline", "function": "show_traction", "notes": "The slide uses a non-linear, interconnected circular node design to represent a timeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/3", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "The slide combines team bios with business model and partnership validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/4", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a structured layout to categorize problems into three pillars: cost/risk, time, and efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/5", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-5", "loopMatches": [ { "to": 5, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "430ef127-0d18-4b80-88fd-ce85baaa04bc", "evidence": "The deck highlights the challenges in pharma R&D", "position": 0, "objective": "Highlight the cost of inaction in pharma R&D", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "515fad29-c5fd-4c20-bbc1-cb4057f00579", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The deck identifies the problem in pharma R&D", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "mission", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/6", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-6", "loopMatches": [ { "to": 6, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "4c24b049-cf14-4d0a-9379-f221d4492c96", "evidence": "The deck presents the value proposition of BenevolentAI", "position": 1, "objective": "Present the value proposition of BenevolentAI", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "1e6d9f25-0a88-46f2-ad62-cacadd88424e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents BenevolentAI's solution to address the challenges in pharma R&D", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "business_model", "function": "present_solution", "notes": "The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/7", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to illustrate the drug discovery pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/8", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular arrow graphic to represent a feedback loop between in-silico and in-vitro processes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/9", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/10", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a timeline on the left and a summary of partnership terms on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/11", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/12", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "roadmap", "function": "show_traction", "notes": "The slide uses a Gantt-style chart to show the progress of different drug programs. It distinguishes between proprietary (teal) and partner (yellow) pipelines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/13", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "Includes two process diagrams illustrating the Benevolent Platform's role and the experimental validation process.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/14", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "competitive_analysis", "function": "cite_precedent", "notes": "The slide uses a table to demonstrate market validation for early-stage IBD assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/15", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "fdc56906-08e0-4e86-a37e-90ad391e4df6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The deck discusses the market size and potential for BenevolentAI's solution", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "why_now", "function": "argue_timing", "notes": "The slide uses a causal chain logic to connect market deal activity and clinical unmet needs to the value proposition of the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/16", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-16", "loopMatches": [ { "to": 16, "from": 16, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "cd213991-b6ad-4532-a083-168c9a37beb2", "evidence": "The deck explains why now is the right time for BenevolentAI", "position": 2, "objective": "Explain why now is the right time for BenevolentAI", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a two-row structure to contrast 'Collaborations' and 'Out licensing' business models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/17", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "testimonial", "function": "cite_precedent", "notes": "The slide uses a grid layout to present three distinct partner endorsements with associated logos and investment figures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/18", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "summarize", "notes": "The slide uses a grid layout to present financial KPIs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/19", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 19, "beatId": "00ba027f-422b-4429-89db-b82101c8b1da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The deck presents financial highlights", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a vertical list format to present the investment thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/20", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/21", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "team_bio", "function": "other", "notes": "Includes corporate structure details, shareholder list, and headshots of leadership.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/22", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/23", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 23, "from": 23, "beatId": "d2ac2a00-8894-4e20-94e9-4fe7863b2d44", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The deck agitates the problem by highlighting the challenges in discovering and developing medicines", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "value_proposition", "function": "present_solution", "notes": "The slide uses a split-screen approach to contrast two distinct value drivers: cost reduction and success rate improvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/24", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a table format to demonstrate differentiation and market potential for five specific pipeline assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/25", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "The slide outlines a standard clinical trial structure (SAD, Food Effect, MAD) and highlights the competitive advantage of a clean safety profile compared to historical PDE10 inhibitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/26", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The slide emphasizes the absence of CNS-associated adverse events, which is a key differentiator for this PDE10 inhibitor.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/27", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a combination of text, scientific charts (dose-response curves), and a process diagram to validate the drug's mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/28", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a honeycomb/network diagram to represent data integration and processing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/29", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to map specific technical capabilities to stages of drug discovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/30", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2ede-72aa-ade1-9df6586a5c43", "docSlug": "07da8690ded5d079d6760889d2f598d8", "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides", "authorId": "benevolentai", "authorName": "BenevolentAI", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a three-column layout to categorize value drivers: proprietary pipeline, partnerships, and future growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/31", "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43", "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-2fc4-7749-bd54-797b0faf3e69", "docSlug": "2b416e7284dddcc25adf7cd1f778e242", "documentTitle": "Delivery Hero | Investor Presentation Deck | 54 slides", "authorId": "delivery-hero", "authorName": "Delivery Hero", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/xpxhLu45RxPSf8J7ngmKiKeJhXMBx4JsZuMrjMDLoxY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYjQxNmU3Mjg0ZGRkY2MyNWFkZjdjZDFmNzc4ZTI0Mi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2fc4-7749-bd54-797b0faf3e69/1", "deckHref": "/decks/019de077-2fc4-7749-bd54-797b0faf3e69", "deckAnchorHref": "/decks/019de077-2fc4-7749-bd54-797b0faf3e69#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/LtjiT6VC_vOsnespesq-C_htFgfAcbNoDprrlPBvvQ0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYjQxNmU3Mjg0ZGRkY2MyNWFkZjdjZDFmNzc4ZTI0Mi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/YSevRMV40_xPMM-3hJwjF3ZRuQNtvHMuhabHt4jqu8M/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYjQxNmU3Mjg0ZGRkY2MyNWFkZjdjZDFmNzc4ZTI0Mi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/OfahnB4HxQihEJHl3Z9Oan8GRQw6VKIidk4jE5jRvMc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYjQxNmU3Mjg0ZGRkY2MyNWFkZjdjZDFmNzc4ZTI0Mi9wMDAxLnBuZw" }, { "docId": "019de077-2fc4-7749-bd54-797b0faf3e69", "docSlug": "2b416e7284dddcc25adf7cd1f778e242", "documentTitle": "Delivery Hero | Investor Presentation Deck | 54 slides", "authorId": "delivery-hero", "authorName": "Delivery Hero", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-2fc4-7749-bd54-797b0faf3e69/2", "deckHref": "/decks/019de077-2fc4-7749-bd54-797b0faf3e69", "deckAnchorHref": "/decks/019de077-2fc4-7749-bd54-797b0faf3e69#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }